V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005353 | 320006638 | null | 79.2 | Palliative (P) | 2015-12-30 | 2016-01-28 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | 320017653 | IBRUTINIB |
| 320005354 | 320006638 | 1.7 | 78.5 | Palliative (P) | 2016-09-29 | 2016-10-06 | Irinotecan + Temozolomide | N | N | 320017653 | CARBOPLATIN + RT |
| 320005355 | 320003681 | 1.58 | 70.5 | Neo-adjuvant (N) | 2015-01-08 | 2015-01-15 | Capecitabine | N | N | 320017665 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320005356 | 320003682 | 1.87 | 94.2 | Curative (C) | 2015-11-09 | 2015-12-03 | Enzalutamide | N | N | 320017674 | CISPLATIN + FLUOROURACIL + RT |
| 320005357 | 320003683 | null | null | Palliative (P) | 2016-11-13 | 2017-02-23 | Trifluridine + Tipiracil | N | null | 320017677 | CARBOPLATIN + RT |
| 320005358 | 320003684 | 0 | 62.7 | Curative (C) | 2017-03-01 | 2017-03-28 | Capecitabine + Cisplatin | N | N | 320017678 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 320005359 | 320003684 | 1.54 | 53 | Palliative (P) | 2015-08-05 | 2015-08-21 | CAPECITABINE + OXALIPLATIN | Y | N | 320017678 | ICON TRIAL |
| 320005360 | 320003687 | 1.7 | 15 | Adjuvant (A) | 2016-09-26 | 2016-09-26 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 320017683 | CETUXIMAB + RT |
| 320005361 | 320006639 | 1.64 | null | Palliative (P) | 2015-10-15 | 2015-12-31 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 320017705 | DOCETAXEL |
| 320005362 | 320003688 | null | 93.9 | Neo-adjuvant (N) | 2015-12-14 | 2015-12-15 | ICON8 TRIAL | 02 | null | 320017715 | CISPLATIN + PACLITAXEL |
| 320005365 | 320003692 | 1.63 | 76.9 | Curative (C) | 2013-12-03 | 2013-12-10 | CARBOPLATIN + RT | N | N | 320017741 | CHOP R |
| 320005366 | 320003693 | 1.6 | 0 | Palliative (P) | 2013-12-26 | 2013-12-26 | Paclitaxel+Trastuzumab 21 day Maint | 02 | N | 320017746 | CHOP R |
| 320005367 | 320003694 | 1.6 | 60.4 | Curative (C) | 2016-02-20 | 2016-06-23 | Niraparib | 02 | N | 320017756 | CISPLATIN + GEMCITABINE |
| 320005368 | 320003695 | 1.62 | 50.6 | Curative (C) | 2017-09-09 | 2017-09-12 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | 320017764 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320005369 | 320003696 | 1.61 | null | Curative (C) | 2018-04-07 | 2018-04-14 | Cisplatin + Vinorelbine (IV) | N | N | 320017787 | VINBLASTINE |
| 320005370 | 320003700 | 1.65 | 71.3 | Adjuvant (A) | 2016-04-23 | 2016-04-23 | HCX (Cape + Cisp + Tras) - Main | 2 | N | 320017790 | ICON8B TRIAL |
| 320005371 | 320003702 | null | 56.5 | Adjuvant (A) | 2014-09-07 | 2014-12-28 | Cisplatin + Etoposide (3 day) | 02 | N | 320017824 | CARBOPLATIN + ETOPOSIDE |
| 320005372 | 320003702 | 1.73 | 78 | Adjuvant (A) | 2016-10-08 | 2016-10-15 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 320017824 | CARBOPLATIN + CETUXIMAB + FU |
| 320005373 | 320003702 | 1.73 | 69 | Curative (C) | 2015-01-30 | 2015-02-06 | IVA | 02 | null | 320017824 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005374 | 320003702 | 1.55 | 75.65 | Adjuvant (A) | 2018-06-04 | 2018-06-25 | Rituximab | N | N | 320017824 | NIVOLUMAB |
| 320005375 | 320003702 | 1.7 | 57.4 | Curative (C) | 2018-08-26 | 2018-08-26 | Temozolomide 150mg/m2 | 02 | Y | 320017824 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320005376 | 320003703 | 1.7 | 92.5 | Palliative (P) | 2015-05-06 | 2017-02-27 | PEMBROLIZUMAB | N | N | 320017913 | BORTEZOMIB |
| 320005377 | 320003704 | null | 85.5 | Curative (C) | 2016-04-29 | 2016-05-06 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | Y | 320017920 | CARBOPLATIN + ETOPOSIDE |
| 320005378 | 320003705 | 1.6 | 103 | Palliative (P) | 2018-02-11 | 2018-02-21 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 320017939 | POMALIDOMIDE |
| 320005379 | 320003705 | 1.6 | 81.6 | null | 2018-12-03 | 2018-12-10 | Carbo F | 02 | N | 320017939 | TRABECTEDIN |
| 320005380 | 320003707 | 1.77 | 87.5 | Curative (C) | 2018-05-22 | 2018-06-02 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | Y | 320017944 | TRIFLURIDINE + TIPIRACIL |
| 320005381 | 320003708 | 1.63 | 56.7 | Palliative (P) | 2015-12-18 | 2015-12-25 | BCG Intravesical | 02 | N | 320017956 | TEMOZOLOMIDE |
| 320005382 | 320003709 | 1.61 | 62.8 | Adjuvant (A) | 2016-12-04 | 2016-12-19 | CISPLATIN + GEMCITABINE | 2 | N | 320017969 | IMATINIB |
| 320005383 | 320003709 | 1.7 | 96.7 | Palliative (P) | 2015-10-26 | 2015-10-28 | Capecitabine + Oxaliplatin 14day | N | null | 320017969 | NIVOLUMAB |
| 320005384 | 320003709 | 1.52 | 64.5 | Curative (C) | 2018-05-12 | 2018-05-18 | Topotecan IV 7 day | 02 | N | 320017969 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320005385 | 320007436 | 1.42 | 60.8 | null | 2015-09-16 | 2015-09-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320018017 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 320005386 | 320003711 | 1.82 | 55.8 | Curative (C) | 2014-03-06 | 2014-06-18 | VAC | 02 | N | 320018047 | CETUXIMAB + RT |
| 320005387 | 320003713 | 1.78 | 84.4 | Adjuvant (A) | 2018-10-17 | 2018-10-17 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 320018066 | CARBO + FLUOROURACIL |
| 320005388 | 320003714 | 1.63 | 68.8 | Curative (C) | 2018-04-29 | 2018-05-15 | POUT TRIAL | 02 | N | 320018067 | ICON TRIAL |
| 320005389 | 320005696 | 1.53 | 42.4 | Curative (C) | 2015-01-30 | 2016-11-11 | VAI (Ifos 3g/m2) | N | N | 320018083 | VINCRISTINE |
| 320005390 | 320006643 | 1.7 | null | Adjuvant (A) | 2016-08-03 | 2016-08-03 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 320018100 | CAPE + CARBOPLATIN + CETUXIMAB |
| 320005391 | 320003717 | 1.82 | 51.5 | Adjuvant (A) | 2017-11-12 | 2017-11-25 | Niraparib | null | null | 320018100 | ICON8B TRIAL |
| 320005392 | 320003718 | 1.64 | 0 | Curative (C) | 2016-07-21 | 2016-07-21 | AFLIBERCEPT + FU + IRINOTECAN | 2 | N | 320018109 | IVA |
| 320005393 | 320003719 | 1.76 | 71.4 | Adjuvant (A) | 2015-07-30 | 2015-09-07 | AFLIBERCEPT + FU + IRINOTECAN | Y | N | 320018110 | CARBOPLATIN + ETOPOSIDE |
| 320005394 | 320003720 | 1.54 | 0 | Palliative (P) | 2014-11-11 | 2015-04-20 | Docetaxel | Y | N | 320018148 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320005395 | 320003721 | 1.6 | 78.1 | Adjuvant (A) | 2013-09-16 | 2013-09-18 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | Y | 320018151 | GEMCITABINE |
| 320005396 | 320003721 | 1.52 | 79.399 | Palliative (P) | 2015-06-05 | 2015-08-07 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 320018151 | TEMOZOLOMIDE |
| 320005397 | 320003722 | null | 42.1 | Palliative (P) | 2014-07-20 | 2014-07-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 320018235 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005398 | 320003723 | 1.68 | 75.2 | Curative (C) | 2017-02-22 | 2017-03-21 | Cetuximab + Radiotherapy Maint | null | null | 320018237 | CETUXIMAB + RT |
| 320005399 | 320003726 | 1.7 | 84.8 | Adjuvant (A) | 2018-08-19 | 2018-08-21 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 320018243 | CISPLATIN + GEMCITABINE |
| 320005400 | 320005701 | 1.53 | 81.9 | Palliative (P) | 2017-05-24 | 2017-07-20 | CARBOPLATIN + RT | 02 | N | 320018257 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 320005401 | 320005701 | 1.67 | 59.9 | Palliative (P) | 2018-12-23 | 2019-01-20 | CARBOPLATIN + CETUXIMAB + FU | N | null | 320018257 | CAPECITABINE + OXALIPLATIN |
| 320005402 | 320005701 | 1.68 | 113 | Curative (C) | 2016-10-10 | 2016-10-20 | Trabectedin | 02 | N | 320018257 | ICON8B TRIAL |
| 320005403 | 320003728 | 1.76 | 70 | Palliative (P) | 2014-10-08 | 2014-10-08 | ECX | N | N | 320018290 | IVADO |
| 320005404 | 320003728 | 1.76 | 101 | Palliative (P) | 2016-04-04 | 2016-04-05 | CNS LGG 2004 03 vinc weekly+ carbo | 2 | N | 320018290 | MITOMYCIN INTRAVESICULAR |